By Elaine Rigoli
Tampa, Fla., Sept. 14 - EastMed, Inc. has secured $1.5 million in initial financing from InNOVAcorp and BDC Venture Capital's Technology Seed Investments fund, a division of the Business Development Bank of Canada.
The company said the investment will fund clinical improvements and marketing initiatives to support the launch of the company's new product that will be marketed under the brand name Uresta. The product is designed to help women control stress urinary incontinence.
EastMed is a medical manufacturing company based in Halifax, Nova Scotia.
| Issuer: | EastMed, Inc.
|
| Amount: | $1.5 million
|
| Investors: | InNOVAcorp and BDC Venture Capital's Technology Seed Investments fund, a division of the Business Development Bank of Canada
|
| Announcement date: | Sept. 14
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
